source
- Erasca reports RAS cancer drug data after legal threat from RevolutionAfter a new drug from Revolution Medicines reignited hopes for treating pancreatic cancer, a rival compound from Erasca — which released early-stage data on Monday — could prompt a legal showdown b…Endpoints · 3mo ago↗ source
- Revolution Medicines threatens to sue Erasca over patent, efficacy claimsEarlier this month, a new cancer drug captivated patients and investors. Now the lawyers get their turn. On Monday, Erasca said it had received a legal threat from Revolution Medicines' lawyers ove…Endpoints · 3mo ago↗ source
- Utah doctors demand suspension of Doctronic AI programMembers of Utah’s medical licensing board have called for the suspension of a temporary program allowing a startup to use AI to refill prescription medications. The startup, Doctronic, struck an ag…